These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


596 related items for PubMed ID: 25769098

  • 1. De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system.
    Abdel-Razik A, Mousa N, Elhelaly R, Tawfik A.
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):585-92. PubMed ID: 25769098
    [Abstract] [Full Text] [Related]

  • 2. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development.
    Zocco MA, Di Stasio E, De Cristofaro R, Novi M, Ainora ME, Ponziani F, Riccardi L, Lancellotti S, Santoliquido A, Flore R, Pompili M, Rapaccini GL, Tondi P, Gasbarrini GB, Landolfi R, Gasbarrini A.
    J Hepatol; 2009 Oct; 51(4):682-9. PubMed ID: 19464747
    [Abstract] [Full Text] [Related]

  • 3. A single hospital study on portal vein thrombosis in cirrhotic patients - clinical characteristics & risk factors.
    Chen H, Trilok G, Wang F, Qi X, Xiao J, Yang C.
    Indian J Med Res; 2014 Feb; 139(2):260-6. PubMed ID: 24718401
    [Abstract] [Full Text] [Related]

  • 4. Reversed portal flow: Clinical influence on the long-term outcomes in cirrhosis.
    Kondo T, Maruyama H, Sekimoto T, Shimada T, Takahashi M, Yokosuka O.
    World J Gastroenterol; 2015 Aug 07; 21(29):8894-902. PubMed ID: 26269679
    [Abstract] [Full Text] [Related]

  • 5. Impact of portal hemodynamics on Doppler ultrasonography for predicting decompensation and long-term outcomes in patients with cirrhosis.
    Kondo T, Maruyama H, Sekimoto T, Shimada T, Takahashi M, Okugawa H, Yokosuka O.
    Scand J Gastroenterol; 2016 Aug 07; 51(2):236-44. PubMed ID: 26357874
    [Abstract] [Full Text] [Related]

  • 6. Doppler hemodynamic study in portal hypertension and hepatic encephalopathy.
    Perisic M, Ilic-Mostic T, Stojkovic M, Culafic D, Sarenac R.
    Hepatogastroenterology; 2005 Aug 07; 52(61):156-60. PubMed ID: 15783018
    [Abstract] [Full Text] [Related]

  • 7. [Clinical features of liver cirrhosis complicated by portal vein thrombosis and related risk factors].
    Lin GS, Xu Q, Zhao SY, Zhang YX.
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jul 20; 24(7):513-517. PubMed ID: 27784429
    [Abstract] [Full Text] [Related]

  • 8. Portal and splenic hemodynamics in cirrhotic patients: relationship between esophageal variceal bleeding and the severity of hepatic failure.
    Kayacetin E, Efe D, Doğan C.
    J Gastroenterol; 2004 Jul 20; 39(7):661-7. PubMed ID: 15293137
    [Abstract] [Full Text] [Related]

  • 9. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
    Noronha Ferreira C, Reis D, Cortez-Pinto H, Tato Marinho R, Gonçalves A, Palma S, Leite I, Rodrigues T, Pedro AJ, Alexandrino P, Serejo F, Sobral Dias M, Ferreira P, Vasconcelos M, Damião F, Xavier Brito L, Baldaia C, Fatela N, Ramalho F, Velosa J.
    Dig Dis Sci; 2019 Sep 20; 64(9):2671-2683. PubMed ID: 30852769
    [Abstract] [Full Text] [Related]

  • 10. Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case-control study.
    Stine JG, Wang J, Shah PM, Argo CK, Intagliata N, Uflacker A, Caldwell SH, Northup PG.
    Liver Int; 2018 Jan 20; 38(1):94-101. PubMed ID: 28632958
    [Abstract] [Full Text] [Related]

  • 11. The impact of portal vein thrombosis on the prognosis and liver function of nonmalignant cirrhotic patients.
    Endo K, Oikawa T, Kakisaka K, Tamura A, Ehara S, Takikawa Y.
    Scand J Gastroenterol; 2018 Jan 20; 53(10-11):1340-1346. PubMed ID: 30257110
    [Abstract] [Full Text] [Related]

  • 12. Splenic Doppler impedance indices: influence of different portal hemodynamic conditions.
    Bolognesi M, Sacerdoti D, Merkel C, Gerunda G, Maffei-Faccioli A, Angeli P, Jemmolo RM, Bombonato G, Gatta A.
    Hepatology; 1996 May 20; 23(5):1035-40. PubMed ID: 8621130
    [Abstract] [Full Text] [Related]

  • 13. [Portal vein flow rate used as a early predictor of portal vein thrombosis after periesophagastric devascularization].
    Zhang Y, Wen TF, Chen ZY, Yan LN, Liang GL, Li G, Zhang XH, Ran S, Liao ZX.
    Zhonghua Wai Ke Za Zhi; 2009 Jun 01; 47(11):825-8. PubMed ID: 19961011
    [Abstract] [Full Text] [Related]

  • 14. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis.
    Amitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, Grandone E, Balzano A.
    J Hepatol; 2004 May 01; 40(5):736-41. PubMed ID: 15094219
    [Abstract] [Full Text] [Related]

  • 15. Platelet indices in patients with de novo portal vein thrombosis and liver cirrhosis.
    Gîrleanu I, Trifan A, Cojocariu C, Dimache M, Sîngeap AM, Stoica O, Sfarti C, Stanciu C.
    Rev Med Chir Soc Med Nat Iasi; 2013 May 01; 117(3):641-7. PubMed ID: 24502029
    [Abstract] [Full Text] [Related]

  • 16. Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension.
    Kinjo N, Kawanaka H, Akahoshi T, Tomikawa M, Yamashita N, Konishi K, Tanoue K, Shirabe K, Hashizume M, Maehara Y.
    Br J Surg; 2010 Jun 01; 97(6):910-6. PubMed ID: 20474001
    [Abstract] [Full Text] [Related]

  • 17. De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes.
    Maruyama H, Okugawa H, Takahashi M, Yokosuka O.
    Am J Gastroenterol; 2013 Apr 01; 108(4):568-74. PubMed ID: 23381015
    [Abstract] [Full Text] [Related]

  • 18. Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients.
    Ghabril M, Agarwal S, Lacerda M, Chalasani N, Kwo P, Tector AJ.
    Transplantation; 2016 Jan 01; 100(1):126-33. PubMed ID: 26050013
    [Abstract] [Full Text] [Related]

  • 19. Doppler Ultrasound in Liver Cirrhosis: Correlation of Hepatic Artery and Portal Vein Measurements With Model for End-Stage Liver Disease Score.
    Park HS, Desser TS, Jeffrey RB, Kamaya A.
    J Ultrasound Med; 2017 Apr 01; 36(4):725-730. PubMed ID: 28026900
    [Abstract] [Full Text] [Related]

  • 20. Color Doppler velocity profile assessment of portal hemodynamics in cirrhotic patients with portal hypertension: correlation with esophageal variceal bleeding.
    Yin XY, Lu MD, Huang JF, Xie XY, Liang LJ.
    J Clin Ultrasound; 2001 Jan 01; 29(1):7-13. PubMed ID: 11180179
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 30.